Astec Lifesciences is coming out with an initial public offering (IPO) of 75,00,000 equity shares of Rs 10 each for cash at a price of Rs 77-82 per equity share, aggregating Rs 57.75-61.50 crore.
The company is engaged in the manufacture and sale of intermediates, active ingredients and formulations in the off patent–proprietary category with a focus on agrochemical and pharmaceutical sector.
It carries out manufacturing activities at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra.
The issue comprises a reservation of 1,00,000 equity shares for subscription by eligible employees at the issue price, and net issue of 74,00,000 equity shares. The issue constitutes 44.30% of the fully diluted post issue paid-up capital of the company.
The money raised via issue will be used for expansion of existing manufacturing facilities at Mahad, Maharashtra (at cost of Rs 31.24 crore); expansion of existing research and development facility at Dombivli, Maharashtra (at Rs 2.46 crore); meeting registration expenses (at Rs 3.69 crore) and meeting long-term working capital requirements (at Rs 11 crore).
The equity shares are proposed to be listed on the Bombay Stock Exchange and National Stock Exchange of India.
Almondz Global Securities Limited is the book running lead manager and IDBI Capital Market Services Ltd is the co-book running lead manager to the issue. Bigshare Services Private Ltd is the registrar to the issue.
Please follow the basic steps before investing in any script either from market or during ipo:
1.check the company last 4-5 years track record 2. Check the PE of the market leader in that sector and compare with the PE of the script 3. Go through at least 6 months news of the company.. about their future plans, achievements, etc
After analyzing this few basic points, you himself decide whether the script is good to buy or not.
DEN Previous record poor as per balance sheet & history of performance, Moreover peer to the co. are ahead Poor (knowledgewise) investor.....have option of secondary market....but human tendency....this will surely perform???? But on What grounds......
dont apply on den ipo because all DTH are not so much profitable, 2 years ago dish tv ipo will come and listed at discount and dish tv is much more bigger company then DEN.